Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2007Headache The Journal of Head and Face Pain

Topiramate in Migraine Prophylaxis: Long‐Term Impact on Resource Utilization and Cost

View Full Paper
Ask AI
Bookmark
Share

Authors

SSStephen D. SilbersteinAstraZeneca (United Kingdom)AFAnthony L. FeliuMemorial Sloan Kettering Cancer CenterMRMarcia F.T. RupnowJanssen (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Silberstein et al. (2007) studied this question.

synapsesocial.com/papers/6aaa63baac6343f54cdfe703https://doi.org/10.1111/j.1526-4610.2007.00754.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of Topiramate Migraine Prophylaxis on Workplace Productivity: Results from Two US Randomized, Double-Blind, Placebo-Controlled, Multicenter Trials2007 · 17 citations
  2. 2Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache2002 · 226 citations
  3. 3Prevalence of Selected Chronic Conditions: United States, 1983-851988 · 389 citations
  4. 4Topiramate in Migraine Prevention2004 · 529 citations
  5. 5Topiramate for Migraine Prevention<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>2004 · 657 citations